Literature DB >> 1615286

Affinity purification of antigen-specific serum immunoglobulin from the European eel (Anguilla anguilla).

K Buchmann1, L Ostergaard, J Glamann.   

Abstract

Immunization of specimens of the European eel with a hapten-carrier conjugate resulted in a significant rise in anti-hapten titres. Antigen-specific immunoglobulin was purified on a matrix onto which the hapten-carrier conjugate had been immobilized. Rabbit antisera raised against the product of the affinity purification recognized two molecular moieties. The first was eel immunoglobulin as inferred by the polypeptide composition, i.e. disulphide-linked heavy and light chains of 72 kDa and 25 kDa respectively. The second was a 110-kDa protein. A 800-kDa and a 400-kDa molecular form of eel immunoglobulin were disclosed by a combination of gel filtration and immunoelectrophoretic detection. The latter was the more abundant serum form. The 110-kDa protein was found non-covalently associated with the 400-kDa immunoglobulin. Both molecular forms of immunoglobulin from immune sera exhibited antigenic specificity and reactivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615286     DOI: 10.1111/j.1365-3083.1992.tb02944.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Association between immunisation, reduced weight gain and plasma cortisol concentrations in juvenile Baltic salmon (Salmo salar).

Authors:  M Engelbrecht Nielsen; K Buchmann
Journal:  Acta Vet Scand       Date:  1997       Impact factor: 1.695

2.  Purification and characterization of IgM-like immunoglobulin from turbot (Scophthalmus maximus L.).

Authors:  H Kofod; K Pedersen; J L Larsen; K Buchmann
Journal:  Acta Vet Scand       Date:  1994       Impact factor: 1.695

3.  CD4+CD25+ immunoregulatory T cells may not be involved in controlling autoimmune arthritis.

Authors:  Tamas Bardos; Matyas Czipri; Csaba Vermes; Alison Finnegan; Katalin Mikecz; Jian Zhang
Journal:  Arthritis Res Ther       Date:  2003-01-20       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.